SL
Sandler Laura Lee
首席运营官
OFFICERF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Sandler Laura Lee, 首席运营官. Insider active across 1 company, notably Oruka Therapeutics, Inc.. Cumulatively, 14 filings have been recorded. Split: 0 buy · 9 sells. Total volume traded: €689k. Activity tracked since 2 January 2026. The latest transaction was filed on 1 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Sandler Laura Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
5,000 股@ US$7.80Common StockSEC:0000907654-26-000088:0
1,000 股@ US$91.0476Common StockSEC:0000907654-26-000088:1
4,000 股@ US$92.0134Common StockSEC:0000907654-26-000088:2
5,000 股@ US$7.800.0005% mcap8.9% 占其流量Common StockSEC:0000907654-26-000037:0
2,200 股@ US$62.58430.0019% mcap31.6% 占其流量Common StockSEC:0000907654-26-000037:1
1,800 股@ US$64.14880.0016% mcap26.5% 占其流量Common StockSEC:0000907654-26-000037:2
300 股@ US$65.100.0003% mcap4.5% 占其流量Common StockSEC:0000907654-26-000037:3
400 股@ US$66.0550.0004% mcap6.1% 占其流量Common StockSEC:0000907654-26-000037:4
200 股@ US$67.1550.0002% mcap3.1% 占其流量Common StockSEC:0000907654-26-000037:5
100 股@ US$68.480.0001% mcap1.6% 占其流量Common StockSEC:0000907654-26-000037:6
600 股@ US$41.306.0% 占其流量Common StockSEC:0000907654-26-000031:0
5,000 股@ US$7.808.4% 占其流量Common StockSEC:0000907654-26-000022:0
32,500 股0Common StockSEC:0000907654-26-000017:0
5,000 股@ US$7.800.0005% mcap50.0% 占其流量Common StockSEC:0000907654-26-000002:0
About Sandler Laura Lee
Laura Lee Sandler is Chief Operating Officer at Oruka Therapeutics, Inc. She has 11 filings in total, and in the sampled recent filings from 2026-01-02 to 2026-05-01, the reported activity is a sale, with EUR 0 of purchases and EUR 293971 of sales.